Michelle Mellion

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

James F. Howard, Richard J. Barohn, Gary Cutter et al. · Muscle & Nerve · 2013 · 223 citations

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 173 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +5

Safety of nerve conduction studies in patients with implanted cardiac devices

Andreas P. Schoeck, Michelle Mellion, James M. Gilchrist et al. · Muscle & Nerve · 2006 · 51 citations

Small-Fiber Degeneration in Alcohol-Related Peripheral Neuropathy

Michelle Mellion, Elizabeth Silbermann, James M. Gilchrist et al. · Alcoholism Clinical and Experimental Research · 2014 · 44 citations · Full text